Goodrx Holdings, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
The Vanguard Group has reported 0% beneficial ownership in GoodRx Holdings Inc. following an internal realignment.
NASDAQ
SCHEDULE: Vanguard Boosts GoodRx Stake to 9.33%
The Vanguard Group has reported an increased beneficial ownership of 9.33% in GoodRx Holdings Inc, holding over 9.2 million shares.
NASDAQ
SCHEDULE 13G/A: Ameriprise Financial and Columbia Management Reduce Stake in GoodRx Holdings Below 5%
Ameriprise Financial, Inc. and its subsidiary Columbia Management Investment Advisers, LLC have reported reducing their beneficial ownership in GoodRx Holdings, Inc. Class A Common Stock to 4.3% as of March 31, 2025.
NASDAQ
Rubric Capital Management LP and David Rosen have filed an amended Schedule 13G, indicating they no longer hold a reportable beneficial ownership stake in GoodRx Holdings, Inc. as of March 31, 2025.
NASDAQ
Rubric Capital Management LP and David Rosen have disclosed a passive beneficial ownership of 5.57% in GoodRx Holdings, Inc.'s Class A Common Stock.
NASDAQ
Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander jointly report beneficial ownership of 2,186,869 shares of GoodRx Holdings, Inc., representing 2.1% of the company's Class A Common Stock.